Pfizer partners Ophthalmological Society to combat glaucoma
Daily GRaphic Health
Pfizer, a pharmaceutical company, has partnered the Ophthalmological Society of Ghana to address the growing challenges of glaucoma in the country. The partnership followed after the two institutions had expressed concerns over the rising cases of glaucoma in the country during the World Glaucoma Week held recently.
A statement issued by the President of the Glaucoma Working Group of the Ophthalmological Society of Ghana, Dr Seth Fiadoyor, said: “Glaucoma has become a public health issue in Ghana which needs to be given optimum attention.”
He said there was a need for concerted efforts by all stakeholders to address the problem, adding that the country must not wait till the situation becomes worse.
The Medical Director of Pfizer, Dr Kodjo Soroh, underscored the need for Ghanaians to undergo regular checkups for early detection of glaucoma “as most types of the condition progress towards visual damage and may lead to irreversible blindness.”
“Pfizer is committed to contributing positively to patient care in all the communities they operate in, while exploring more opportunities with relevant stakeholders to create awareness of the importance of regular eye checks to reduce the burden of glaucoma,” Dr Soroh added.
During the Glaucoma Week, the two institutions organised free screening for residents in Akosombo, Koforidua and Accra.